Curcuma longa (turmeric) or its active ingredients for osteoarthritis

Ivan Shirinsky*, Valery Shirinsky, Katerina Filatova, Zeyu Yu, Yuan Chi, Jacqueline Y. Thompson, Chris Bleakley

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the benefits and harms of Curcuma longa extracts or сurcuminoids for osteoarthritis.

Original languageEnglish
Article numberCD014683
Number of pages15
JournalCochrane Database of Systematic Reviews
Volume2021
Issue number7
DOIs
Publication statusPublished - 12 Jul 2021

Bibliographical note

Funding Information:
The methods section is based on the standard Cochrane Musculoskeletal Group Protocol Template. Peer reviewer Dr Benny Antony Senior Research Fellow, Menzies Institute for Medical Research, University of Tasmania and Ms Maureen Smith, Cochrane Consumer, are acknowledged.

Publisher Copyright:
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

ASJC Scopus subject areas

  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Curcuma longa (turmeric) or its active ingredients for osteoarthritis'. Together they form a unique fingerprint.

Cite this